Operator
Ladies and gentlemen, thank you for standing by for Cigna s First Quarter 2021 Results Review. [Operator Instructions] As a reminder, ladies and gentlemen, this conference, including the Q&A session is being recorded.
We ll begin by turning the conference over to Ms. Alexis Jones. Please go ahead, Ms. Jones.
Alexis Jones
Investor Relations Lead Principal
Good morning, everyone, and thank you for joining today s call. I am Alexis Jones, Lead Principal for Investor Relations. With me on the line this morning are: David Cordani, our President and Chief Executive Officer; and Brian Evanko, Cigna s Chief Financial Officer. In our remarks today, David and Brian will cover a number of topics, including Cigna s first quarter 2021 financial results, as well as an update on our financial outlook for 2021.
Operator
Welcome to Evolent Health s earnings conference call for the quarter ended March 31, 2021. As a reminder, this conference call is being recorded. Your host for the call today is Mr. Seth Blackley, chief executive officer of Evolent Health.
This call will be archived and available later this evening and for the next week via the webcast on the company s website in the section entitled Investor Relations. Here is some important introductory information. This call contains forward-looking statements under the U.S. federal securities laws.
These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company s reports that are filed with the Securities and Exchange Commission, including cautionary statements included in the current and periodic filings. For additional information on the company s results an